Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940344 |
US |
2 | |
Cardiac flutter, Feeling jittery, Sleep disorder, Ear disorder, Blood glucose increased, Feeling abnormal, Bone pain, Dizziness, Fatigue, Arthralgia, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 2 | 26940365 |
US |
56 | 2 |
Blood glucose increased, |
||||
INAVOLISIB, PALBOCICLIB, CALCIUM, ERGOCALCIFEROL, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, LINAGLIPTIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FULVESTRANT, INSULIN GLARGINE, INSULIN LISPRO, CETIRIZINE HYDROCHLORIDE, |
||||
| 3 | 26940745 |
US |
2 | |
Blood glucose increased, |
||||
ABALOPARATIDE, |
||||
| 4 | 26942109 |
US |
57 | |
Blood glucose increased, Device issue, Incorrect dose administered, |
||||
INSULIN GLARGINE, |
||||
| 5 | 26942167 |
US |
79 | 2 |
Blood glucose decreased, Blood glucose increased, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN DEGLUDEC, |
||||
| 6 | 26942361 |
US |
42 | 1 |
Feeling abnormal, Blood glucose increased, |
||||
PLOZASIRAN, FENOFIBRATE, ICOSAPENT ETHYL, ROSUVASTATIN, PANTOPRAZOLE SODIUM, ERGOCALCIFEROL, DICYCLOMINE HYDROCHLORIDE, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 7 | 26942665 |
67 | 1 | |
Blood glucose increased, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 8 | 26942810 |
US |
66 | 2 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 9 | 26942844 |
US |
80 | 2 |
Blood glucose increased, Drug ineffective, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 10 | 26942966 |
US |
2 | |
Blood glucose increased, |
||||
ORAL SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 11 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 12 | 26944202 |
US |
57 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, |
||||
| 13 | 26944266 |
US |
2 | |
Blood glucose increased, Vertigo, Dizziness, |
||||
TIRZEPATIDE, |
||||
| 14 | 26944694 |
US |
1 | |
Atypical femur fracture, Neuropathy peripheral, Chronic kidney disease, Nephrolithiasis, Pain, Bone pain, Neck pain, Back pain, Pain, Fall, Balance disorder, Pain in extremity, Myalgia, Tension, Sleep disorder, Attention deficit hyperactivity disorder, Depression, Anxiety, Injection site reaction, Gingival recession, Tooth fracture, Muscular weakness, Fatigue, Fibromyalgia, Abdominal pain, Gastrooesophageal reflux disease, Hypertension, Brain fog, Blood sodium decreased, Blood potassium increased, Blood creatinine increased, Blood glucose increased, Blood parathyroid hormone increased, Alanine aminotransferase decreased, Walking distance test abnormal, Mobility decreased, Activities of daily living decreased, |
||||
ASFOTASE ALFA, |
||||
| 15 | 26944824 |
US |
2 | |
Blood urine present, Gastrooesophageal reflux disease, Balance disorder, Polyuria, Musculoskeletal discomfort, Blood pressure increased, Injection site pain, Injection site erythema, Injection site swelling, Injection site reaction, Nausea, Fatigue, Vertigo, Asthenia, Renal disorder, Blood glucose increased, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, HYOSCYAMINE SULFATE, MAGNESIUM, FLUTICASONE PROPIONATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TAMSULOSIN HYDROCHLORIDE, PEPPERMINT OIL, |
||||
| 16 | 26945687 |
US |
2 | |
Blood glucose increased, Injection site hypertrophy, Headache, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 17 | 26946110 |
US |
71 | 2 |
Blood glucose increased, Tachycardia, |
||||
ABALOPARATIDE, |
||||
| 18 | 26946562 |
US |
1 | |
Blood glucose increased, Blood cholesterol increased, |
||||
SPARSENTAN, |
||||
| 19 | 26946953 |
US |
2 | |
Glucose tolerance impaired, Blood glucose increased, Condition aggravated, |
||||
ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FISH OIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MAGNESIUM, MONTELUKAST SODIUM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 20 | 26946974 |
US |
2 | |
Blood glucose increased, Dizziness, Back pain, |
||||
ABALOPARATIDE, |
||||
| 21 | 26947049 |
US |
66 | 2 |
Blood glucose increased, Product storage issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 22 | 26947105 |
US |
1 | |
Blood glucose increased, Device issue, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 23 | 26947425 |
US |
2 | |
Fall, Blood glucose increased, Back disorder, Product use in unapproved indication, |
||||
ABALOPARATIDE, ABALOPARATIDE, ORAL SEMAGLUTIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BUMETANIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, SUZETRIGINE, MONTELUKAST, RISEDRONATE SODIUM, |
||||
| 24 | 26947474 |
US |
2 | |
Blood glucose increased, |
||||
ABALOPARATIDE, |
||||
| 25 | 26947727 |
US |
2 | |
Respiratory tract infection viral, Blood glucose increased, Feeling abnormal, Respiratory disorder, Weight increased, Drug effect less than expected, Heart rate increased, Fatigue, Abdominal distension, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, TURMERIC, CALCIUM, ERGOCALCIFEROL, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 26 | 26947803 |
US |
68 | 2 |
Blood glucose increased, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 27 | 26947958 |
US |
67 | 2 |
Blood glucose increased, Drug ineffective, Product storage issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, ORAL SEMAGLUTIDE, |
||||
| 28 | 26948229 |
BR |
61 | 2 |
Blood glucose increased, Cataract, Visual impairment, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 29 | 26948240 |
2 | ||
Ankle fracture, Fall, Tibia fracture, Blood glucose increased, Keloid scar, Injection site mass, Visual impairment, Hypoglycaemia, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN LISPRO, |
||||
| 30 | 26951164 |
32 | 2 | |
Dyspnoea, Fibrin D dimer increased, Hypokalaemia, Blood glucose increased, Tachycardia, Sleep disorder, Anxiety, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 31 | 26934314 |
US |
43 | |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 32 | 26934368 |
US |
76 | 2 |
Hepatic cirrhosis, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 33 | 26934529 |
|||
Blood glucose increased, |
||||
FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, GABAPENTIN, |
||||
| 34 | 26934547 |
US |
2 | |
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 35 | 26934628 |
US |
70 | 1 |
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 36 | 26934674 |
US |
73 | |
Hunger, Blood glucose increased, Drug ineffective, |
||||
| 37 | 26934754 |
US |
1 | |
Blood glucose increased, |
||||
OCRELIZUMAB AND HYALURONIDASE, |
||||
| 38 | 26934808 |
US |
1 | |
Pyrexia, Bell^s palsy, Blood glucose increased, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 39 | 26935022 |
US |
56 | 2 |
Blood glucose increased, Drug delivery system malfunction, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 40 | 26935165 |
|||
Blood glucose increased, |
||||
FUROSEMIDE, INSULIN GLARGINE, CLONAZEPAM, SITAGLIPTIN, CHOLESTYRAMINE, LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE, POLYETHYLENE GLYCOL 3350, OXYCODONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DOCUSATE SODIUM, METOPROLOL SUCCINATE, CHOLESTYRAMINE, OLMESARTAN MEDOXOMIL, PRIMIDONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CRIZOTINIB, |
||||
| 41 | 26935436 |
US |
1 | |
Blood glucose increased, Skin ulcer, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, INSULIN LISPRO, PANTOPRAZOLE SODIUM, INSULIN GLARGINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TAMSULOSIN HYDROCHLORIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, LATANOPROST, LOSARTAN POTASSIUM, LOSARTAN, TRAVOPROST, TRAVOPROST (ISOMER FREE), FINASTERIDE, ONDANSETRON HYDROCHLORIDE, BRIMONIDINE TARTRATE, ERYTHROMYCIN, |
||||
| 42 | 26935592 |
US |
78 | 2 |
Blood glucose increased, Inappropriate schedule of product administration, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 43 | 26935598 |
EU |
70 | 1 |
Pericardial effusion, Chronic obstructive pulmonary disease, Cough, Fatigue, Blood glucose increased, Dry mouth, Thirst, Gait disturbance, Hypoglycaemia, Asthenia, |
||||
INSULIN GLARGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DEFLAZACORT, METHYLPREDNISOLONE, |
||||
| 44 | 26935703 |
US |
61 | 2 |
Metastases to central nervous system, Breast cancer, Malignant neoplasm progression, Pneumonia, Confusional state, Metastases to meninges, Hypercalcaemia, Neuropathy peripheral, Carcinoembryonic antigen increased, Mitral valve thickening, Tricuspid valve incompetence, General physical health deterioration, Impaired work ability, Metastases to liver, Metastases to bone, Metastases to lung, Metastases to lymph nodes, Fatigue, Decreased appetite, Hepatic enzyme increased, Oedema peripheral, Weight decreased, Blood cholesterol increased, Asthenia, Lethargy, Feeling cold, Hilar lymphadenopathy, Drug intolerance, Dry skin, Oesophagitis, Radiation associated pain, Constipation, Taste disorder, Haemorrhoidal haemorrhage, Pollakiuria, Pain, Palpitations, Depression, Cough, Pyrexia, Incontinence, Aphasia, Crying, Anhedonia, Transaminases increased, Spinal pain, Stomatitis, Hot flush, Dyspepsia, Dizziness, Insomnia, Alopecia, Burning sensation, Diplopia, Hepatomegaly, Cholelithiasis, Pleural effusion, Lymphadenopathy mediastinal, Bone lesion, Vitamin D decreased, Monocyte count decreased, Blood chloride decreased, Blood urea decreased, Red blood cell count decreased, Alanine aminotransferase increased, Haematocrit decreased, Haemoglobin decreased, Blood albumin decreased, Mean cell haemoglobin decreased, Protein total decreased, Blood creatinine decreased, Blood sodium decreased, Blood calcium decreased, Lymphocyte count decreased, Lymphocyte count increased, Red cell distribution width increased, Carbohydrate antigen 15-3 increased, Blood calcium increased, Mean cell haemoglobin increased, Blood cholesterol increased, Mean cell volume increased, Blood triglycerides increased, Glycosylated haemoglobin increased, Low density lipoprotein increased, Non-high-density lipoprotein cholesterol increased, White blood cell count increased, Blood glucose increased, Blood alkaline phosphatase increased, Aspartate aminotransferase increased, Carbohydrate antigen 27.29 increased, Monocyte count increased, Platelet count increased, Mean cell haemoglobin concentration increased, Blood bilirubin increased, Neutrophil count increased, Prothrombin time prolonged, Urobilinogen urine increased, Protein urine present, Lung infiltration, Aortic valve sclerosis, Mitral valve calcification, Skin exfoliation, |
||||
EVEROLIMUS, LETROZOLE, LETROZOLE TABLETS, FAMOTIDINE, FULVESTRANT, FULVESTRANT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ALPRAZOLAM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ATENOLOL, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, EXEMESTANE, DENOSUMAB, PALBOCICLIB, ALPRAZOLAM, ALPRAZOLAM, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, ESCITALOPRAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, GADOTERATE MEGLUMINE, GADOTERATE MEGLUMINE, FOLIC ACID, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MORPHINE SULFATE, FERROUS SULFATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 45 | 26935942 |
US |
78 | 1 |
Blood glucose increased, Device difficult to use, Incorrect dose administered by device, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 46 | 26936061 |
US |
||
Blood glucose increased, |
||||
SELINEXOR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 47 | 26936566 |
US |
62 | 2 |
Inappropriate schedule of product administration, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 48 | 26936757 |
ZA |
41 | 2 |
Depression, Wound complication, Increased appetite, Weight increased, Diarrhoea, Dizziness, Stress, Blood glucose increased, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 49 | 26937429 |
US |
1 | |
Blood glucose increased, Product dose omission issue, Asthenia, Hyperhidrosis, Malaise, |
||||
ORAL SEMAGLUTIDE, |
||||
| 50 | 26937940 |
CN |
67 | 1 |
Blood glucose increased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, OCTREOTIDE ACETATE, SMOFLIPID, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 51 | 26938265 |
CO |
1 | |
Abdominal pain upper, Diarrhoea, Decreased appetite, Blood glucose increased, Oral disorder, Oropharyngeal pain, Immunosuppressant drug level increased, |
||||
TACROLIMUS, TACROLIMUS, |
||||
| 52 | 26938351 |
US |
72 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 53 | 26938384 |
US |
62 | 1 |
Pneumonia, Blood glucose increased, Tremor, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 54 | 26938692 |
US |
68 | 2 |
Renal impairment, Fall, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 55 | 26938738 |
US |
45 | 2 |
Blood glucose increased, Diabetic ketoacidosis, |
||||
INSULIN LISPRO, |
||||
| 56 | 26938741 |
US |
43 | 1 |
Localised infection, Cardiac disorder, Pericardial effusion, Pulmonary oedema, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 57 | 26938921 |
US |
52 | 1 |
Blood glucose increased, Blood chloride increased, Protein urine, Blood urine, White blood cells urine, Product dose omission issue, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 58 | 26939033 |
US |
2 | |
Blood glucose increased, |
||||
ABALOPARATIDE, |
||||
| 59 | 26939302 |
US |
1 | |
Blood glucose increased, Pain, |
||||
ABALOPARATIDE, |
||||
| 60 | 26939980 |
US |
1 | |
Blood glucose increased, |
||||
TEPROTUMUMAB, |
||||
| 61 | 26931290 |
US |
54 | 2 |
Seizure, Concussion, Blood glucose decreased, Blood glucose increased, Malaise, Headache, Gastrointestinal disorder, Constipation, Off label use, |
||||
ORFORGLIPRON, |
||||
| 62 | 26931321 |
CN |
61 | 2 |
Hepatic function abnormal, Pneumonia, Aortic valve incompetence, Tricuspid valve incompetence, Hepatic function abnormal, Mycoplasma infection, Hyperthyroidism, Hepatic function abnormal, Hepatic cyst, Anaemia, Chest discomfort, Hypoalbuminaemia, Blood glucose increased, Rash, Hyponatraemia, Hepatic function abnormal, Hypoalbuminaemia, Hepatic function abnormal, Hypoalbuminaemia, Hepatic function abnormal, Hypoalbuminaemia, Hyperuricaemia, Uterine leiomyoma, Neutrophil count decreased, Neutrophil count decreased, Hepatic function abnormal, Anaemia, Hepatic function abnormal, |
||||
SOTORASIB, |
||||
| 63 | 26931515 |
1 | ||
Headache, Back pain, Aggression, Sleep disorder, Drug ineffective, Blood glucose increased, Hair growth abnormal, Feeling hot, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SOMATROPIN, DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESCITALOPRAM, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, ALBUTEROL SULFATE, ALBUTEROL, LORATADINE, LORATADINE TABLET, POLYETHYLENE GLYCOL 3350, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, HYDROXYZINE, |
||||
| 64 | 26931956 |
|||
Blood glucose increased, |
||||
PALTUSOTINE, |
||||
| 65 | 26931961 |
US |
49 | |
Blood glucose increased, Accidental underdose, |
||||
PALTUSOTINE, |
||||
| 66 | 26931967 |
US |
51 | |
Thirst, Blood glucose increased, Libido decreased, |
||||
PALTUSOTINE, |
||||
| 67 | 26931995 |
US |
61 | |
Blood glucose increased, |
||||
PALTUSOTINE, PALTUSOTINE, POLYETHYLENE GLYCOL 3350, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 68 | 26932237 |
US |
2 | |
Blindness, Blood glucose increased, |
||||
INSULIN DEGLUDEC, |
||||
| 69 | 26932248 |
US |
71 | 2 |
Kidney infection, Blood glucose increased, Fungal infection, Fatigue, Glycosylated haemoglobin increased, Urinary tract infection, Kidney infection, |
||||
ORAL SEMAGLUTIDE, |
||||
| 70 | 26932614 |
US |
81 | 1 |
Myalgia, Insomnia, Blood glucose increased, |
||||
DUPILUMAB, AMLODIPINE, LISINOPRIL, |
||||
| 71 | 26932630 |
US |
71 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 72 | 26932659 |
US |
70 | 2 |
Blood glucose increased, Drug ineffective, Product storage issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 73 | 26932805 |
US |
57 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN GLARGINE, |
||||
| 74 | 26933539 |
US |
2 | |
Blood glucose increased, Product dose omission issue, Incorrect product administration duration, |
||||
INSULIN LISPRO, |
||||
| 75 | 26933606 |
ZA |
43 | 1 |
Malaise, Blood glucose increased, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 76 | 26933834 |
ZA |
59 | 2 |
Influenza, Dizziness, Illness, Blood glucose increased, |
||||
INSULIN GLULISINE, INSULIN GLARGINE, |
||||
| 77 | 26938133 |
35 | 1 | |
Blood glucose increased, Arthralgia, Joint stiffness, Arthritis, Eye disorder, Dizziness, Anxiety, Nonspecific reaction, Pain in extremity, Fear, Stress, Irritability, Anger, Withdrawal syndrome, Dyskinesia, |
||||
PALIPERIDONE, PALIPERIDONE, PALIPERIDONE, PALIPERIDONE, INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN GLARGINE, ALPRAZOLAM, VITAMIN C, NIACINAMIDE, MAGNESIUM, IRON, |
||||
| 78 | 26926744 |
|||
Hypoglycaemia, Blood glucose increased, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 79 | 26926863 |
EU |
68 | 1 |
Blood glucose increased, Drug dose omission by device, Device breakage, Device leakage, Device failure, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 80 | 26926937 |
EU |
71 | 1 |
Pancytopenia, Pyrexia, Application site erythema, Insomnia, Blood glucose increased, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, BORTEZOMIB, NIFEDIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE, CALCIUM CARBONATE, ANTACID, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, FOLIC ACID, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ALLOPURINOL, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ZOLEDRONIC ACID, |
||||
| 81 | 26926969 |
US |
1 | |
Brain oedema, Blood glucose increased, |
||||
OSIMERTINIB, |
||||
| 82 | 26927005 |
US |
81 | 2 |
Asthma, Blood glucose increased, Decreased appetite, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 83 | 26927091 |
US |
1 | |
Vision blurred, Headache, Depression, Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, ORAL SEMAGLUTIDE, |
||||
| 84 | 26927354 |
US |
59 | 2 |
Incorrect dose administered, Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 85 | 26927721 |
US |
77 | 2 |
Blood glucose increased, Drug ineffective, Blood glucose decreased, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 86 | 26927874 |
US |
40 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO-AABC, |
||||
| 87 | 26928306 |
US |
2 | |
Accidental exposure to product, Blood glucose increased, Device leakage, Device malfunction, Drug dose omission by device, |
||||
INSULIN ASPART, |
||||
| 88 | 26928780 |
US |
1 | |
Blood glucose increased, |
||||
OCRELIZUMAB AND HYALURONIDASE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 89 | 26928903 |
EU |
40 | 1 |
Bronchitis, Gastroenteritis norovirus, Hypokalaemia, Blood glucose increased, Creatine kinase increased, Lymphocyte count decreased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, |
||||
BISOPROLOL FUMARATE, EPLERENONE, SACUBITRIL AND VALSARTAN, EMPAGLIFLOZIN, |
||||
| 90 | 26929157 |
US |
1 | |
Blood glucose increased, |
||||
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, |
||||
| 91 | 26929423 |
19 | ||
Weight increased, Blood glucose increased, Oedema, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 92 | 26929425 |
26 | 1 | |
Cellulitis, Swelling, Blood glucose increased, |
||||
DIAZOXIDE CHOLINE, |
||||
| 93 | 26930142 |
AU |
55 | 2 |
Cachexia, Compression fracture, Gastric antral vascular ectasia, Malignant neoplasm progression, Metastases to bone, Metastases to spine, Upper gastrointestinal haemorrhage, Adverse drug reaction, Blood chromogranin A increased, Blood glucose increased, Bone pain, Coagulopathy, Decreased appetite, Spinal pain, Back pain, |
||||
CAPECITABINE, ZOLEDRONIC ACID, OCTREOTIDE ACETATE, OCTREOTIDE, EVEROLIMUS, EVEROLIMUS TABLETS, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, STREPTOZOCIN, MITOMYCIN, |
||||
| 94 | 26930378 |
US |
72 | 1 |
Blood glucose increased, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 95 | 26930692 |
1 | ||
Blood glucose increased, |
||||
| 96 | 26930717 |
EU |
70 | 1 |
Cataract operation, Visual impairment, Blood glucose increased, Visual acuity reduced, |
||||
POMALIDOMIDE, BORTEZOMIB, BELANTAMAB MAFODOTIN, |
||||
| 97 | 26930777 |
US |
1 | |
Malaise, Blood glucose increased, Product dose omission issue, Inability to afford medication, |
||||
DAPAGLIFLOZIN, |
||||
| 98 | 26930947 |
US |
23 | 2 |
Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 99 | 26921420 |
US |
1 | |
Muscle spasms, Blood glucose increased, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 100 | 26921549 |
US |
||
Visual impairment, Drug ineffective, Blood glucose increased, Device malfunction, |
||||
INSULIN ASPART, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30